{
  "drugAllergyInteractions": {
    "penicillinAllergy": {
      "allergyKeywords": [
        "penicillin",
        "amoxicillin",
        "amoxil",
        "pen-vk"
      ],
      "medicationClasses": [
        "ANTIBIOTIC_PENICILLIN"
      ],
      "severity": "CRITICAL",
      "recommendation": "Avoid all penicillin-class antibiotics. Consider alternatives like macrolides or tetracyclines."
    },
    "sulfaAllergy": {
      "allergyKeywords": [
        "sulfa",
        "sulfonamide",
        "bactrim"
      ],
      "medicationClasses": [
        "ANTIBIOTIC_SULFA",
        "DIURETIC_LOOP",
        "DIURETIC_THIAZIDE"
      ],
      "severity": "CRITICAL",
      "recommendation": "Avoid sulfonamide antibiotics. Use caution with non-antibiotic sulfonamides (like some diuretics), as cross-reactivity is possible but rare. Assess specific allergy history."
    },
    "nsaidAllergy": {
      "allergyKeywords": [
        "nsaid",
        "ibuprofen",
        "naproxen",
        "advil",
        "aleve",
        "aspirin"
      ],
      "medicationClasses": [
        "NSAID",
        "NSAID_COX2"
      ],
      "severity": "CRITICAL",
      "recommendation": "Avoid all NSAIDs. Consider alternative analgesics like acetaminophen."
    }
  },
  "drugDrugInteractions": {
    "warfarinNsaid": {
      "drug1": "WARFARIN",
      "drug2": [
        "NSAID",
        "NSAID_COX2"
      ],
      "severity": "CRITICAL",
      "description": "Concurrent use significantly increases the risk of major bleeding, especially gastrointestinal bleeding, due to antiplatelet effects of NSAIDs and anticoagulation from warfarin.",
      "recommendation": "Avoid combination if possible. If necessary, monitor INR closely and check for signs of bleeding. Consider PPI for GI protection."
    },
    "opioidBenzo": {
      "drug1": [
        "OPIOID_WEAK",
        "OPIOID_STRONG"
      ],
      "drug2": [
        "BENZODIAZEPINE_SHORT_ACTING",
        "BENZODIAZEPINE_LONG_ACTING"
      ],
      "severity": "CRITICAL",
      "description": "Concomitant use of opioids and benzodiazepines causes synergistic CNS depression, leading to profound sedation, respiratory depression, coma, and death.",
      "recommendation": "Avoid combination. If medically necessary, limit doses and duration to the minimum possible and monitor patient closely for sedation and respiratory depression."
    },
    "ssriMaoi": {
      "drug1": [
        "SSRI",
        "SNRI"
      ],
      "drug2": "MAOI",
      "severity": "CRITICAL",
      "description": "Combination can cause serotonin syndrome, a life-threatening condition (symptoms: hyperthermia, rigidity, myoclonus, autonomic instability).",
      "recommendation": "Combination is contraindicated. A washout period of at least 2 weeks (5 weeks for fluoxetine) is required when switching between these classes."
    },
    "aceiPotassiumSparingDiuretic": {
      "drug1": [
        "ACE_INHIBITOR",
        "ARB"
      ],
      "drug2": [
        "DIURETIC_POTASSIUM_SPARING",
        "ALDOSTERONE_ANTAGONIST"
      ],
      "severity": "CRITICAL",
      "description": "Both drug classes increase serum potassium. Concurrent use significantly increases the risk of life-threatening hyperkalemia.",
      "recommendation": "Avoid combination, especially in patients with renal impairment or diabetes. If used, monitor serum potassium levels very closely (like within 1 week of initiation)."
    },
    "statinStrongCyp3a4Inhibitor": {
      "drug1": "CYP3A4_SUBSTRATE",
      "drug2": "CYP3A4_INHIBITOR",
      "severity": "WARNING",
      "description": "Strong CYP3A4 inhibitors (like macrolide antibiotics) can significantly increase plasma concentrations of CYP3A4-metabolized statins (like atorvastatin, simvastatin), increasing the risk of myopathy and rhabdomyolysis.",
      "recommendation": "Avoid combination. If a CYP3A4 inhibitor is required short-term, temporarily hold the statin. Consider statins not metabolized by CYP3A4 (like rosuvastatin, pravastatin)."
    },
    "clopidogrelPpi": {
      "drug1": "CYP2C19_PRODRUG",
      "drug2": "CYP2C19_INHIBITOR",
      "severity": "WARNING",
      "description": "Clopidogrel is a prodrug activated by CYP2C19. Strong CYP2C19 inhibitors (like omeprazole) can reduce its conversion to the active metabolite, decreasing its antiplatelet effect and increasing risk of cardiovascular events.",
      "recommendation": "Avoid combination, particularly with omeprazole and esomeprazole. Consider H2-blockers (like famotidine) or PPIs with weaker CYP2C19 inhibition (like pantoprazole) if acid suppression is needed."
    },
    "ssriNsaid": {
      "drug1": [
        "SSRI",
        "SNRI"
      ],
      "drug2": [
        "NSAID",
        "NSAID_COX2"
      ],
      "severity": "WARNING",
      "description": "Both classes independently increase the risk of gastrointestinal bleeding. The combined risk is synergistic.",
      "recommendation": "Use combination with caution. Monitor for signs of GI bleeding. Consider prescribing a gastroprotective agent (like a PPI) for high-risk patients."
    },
    "lithiumNsaid": {
      "drug1": "MOOD_STABILIZER_LITHIUM",
      "drug2": [
        "NSAID",
        "NSAID_COX2"
      ],
      "severity": "CRITICAL",
      "description": "NSAIDs can reduce renal clearance of lithium, leading to increased serum lithium levels and potential toxicity (symptoms: tremor, confusion, ataxia, seizures).",
      "recommendation": "Avoid combination. Acetaminophen is a safer alternative for analgesia. If NSAID use is unavoidable, monitor lithium levels closely and adjust lithium dose."
    },
    "methotrexateNsaid": {
      "drug1": "DMARD_METHOTREXATE",
      "drug2": [
        "NSAID",
        "NSAID_COX2"
      ],
      "severity": "CRITICAL",
      "description": "NSAIDs can decrease the renal excretion of methotrexate, leading to elevated and prolonged methotrexate concentrations, which can result in severe hematologic and gastrointestinal toxicity.",
      "recommendation": "Avoid combination, especially with high-dose methotrexate. Use with extreme caution in patients on low-dose (like rheumatologic) methotrexate and monitor for signs of toxicity."
    }
  },
  "drugConditionInteractions": {
    "nsaidKidneyDisease": {
      "conditionKeywords": [
        "kidney",
        "renal",
        "ckd",
        "nephropathy"
      ],
      "medicationClasses": [
        "NSAID",
        "NSAID_COX2"
      ],
      "severity": "CRITICAL",
      "description": "NSAIDs inhibit prostaglandins, which are crucial for maintaining renal blood flow. In patients with pre-existing kidney disease, NSAIDs can cause acute kidney injury (AKI) or accelerate progression of chronic kidney disease.",
      "recommendation": "Avoid NSAIDs. Consider alternative analgesics like acetaminophen."
    },
    "metforminRenalImpairment": {
      "conditionKeywords": [
        "kidney",
        "renal",
        "ckd",
        "egfr < 30"
      ],
      "medicationClasses": [
        "BIGUANIDE"
      ],
      "severity": "CRITICAL",
      "description": "Metformin is renally cleared. In severe renal impairment (like eGFR < 30 mL/min/1.73mÂ²), the drug accumulates, increasing the risk of metformin-associated lactic acidosis (MALA), a rare but life-threatening complication.",
      "recommendation": "Metformin is contraindicated in patients with eGFR < 30. Use with caution and dose reduction for eGFR 30-45. Monitor renal function regularly."
    },
    "nonselectiveBetaBlockerAsthma": {
      "conditionKeywords": [
        "asthma",
        "copd",
        "emphysema",
        "bronchitis",
        "wheezing"
      ],
      "medicationClasses": [
        "BETA_BLOCKER_NONSELECTIVE_ALPHA1"
      ],
      "severity": "CRITICAL",
      "description": "Non-selective beta-blockers (like carvedilol, propranolol) block beta-2 receptors in the lungs, which can cause bronchospasm and antagonize the effects of bronchodilators (like albuterol).",
      "recommendation": "Avoid non-selective beta-blockers. If a beta-blocker is required, use a cardioselective (beta-1 selective) agent like Metoprolol Succinate, starting at a low dose."
    },
    "aceInhibitorKidneyDisease": {
      "conditionKeywords": [
        "kidney",
        "renal",
        "ckd"
      ],
      "medicationClasses": [
        "ACE_INHIBITOR",
        "ARB"
      ],
      "severity": "WARNING",
      "description": "ACE inhibitors and ARBs can cause a mild, expected decrease in eGFR upon initiation. However, they can also cause acute kidney injury (especially in bilateral renal artery stenosis) or hyperkalemia.",
      "recommendation": "Use is often protective in CKD (like diabetic nephropathy). Start with a low dose. Monitor serum creatinine and potassium levels 1-2 weeks after initiation or dose titration."
    },
    "corticosteroidDiabetes": {
      "conditionKeywords": [
        "diabetes",
        "hyperglycemia",
        "dm2"
      ],
      "medicationClasses": [
        "CORTICOSTEROID_SYSTEMIC"
      ],
      "severity": "WARNING",
      "description": "Systemic corticosteroids (like prednisone) promote gluconeogenesis and insulin resistance, leading to significant hyperglycemia in patients with diabetes.",
      "recommendation": "Monitor blood glucose levels closely. Proactive adjustment of diabetes medications (like insulin) is often necessary during and after the corticosteroid course."
    },
    "decongestantHypertension": {
      "conditionKeywords": [
        "hypertension",
        "high blood pressure",
        "htn"
      ],
      "medicationClasses": [
        "DECONGESTANT"
      ],
      "severity": "WARNING",
      "description": "Systemic decongestants (like pseudoephedrine) are sympathomimetics that can cause vasoconstriction, leading to an increase in blood pressure.",
      "recommendation": "Avoid in patients with uncontrolled hypertension. Use with caution in controlled hypertension and monitor blood pressure. Consider topical/nasal decongestants for short-term use."
    },
    "anticholinergicBph": {
      "conditionKeywords": [
        "bph",
        "prostate",
        "urinary retention",
        "difficulty urinating"
      ],
      "medicationClasses": [
        "ANTICHOLINERGIC"
      ],
      "severity": "WARNING",
      "description": "Anticholinergic drugs (like diphenhydramine) can decrease detrusor muscle contractility and tighten the bladder neck, worsening symptoms of Benign Prostatic Hyperplasia (BPH) and potentially causing acute urinary retention.",
      "recommendation": "Avoid or use with extreme caution in patients with BPH. Consider alternative medications without anticholinergic properties (like loratadine for allergies)."
    }
  }
}
